204
Participants
Start Date
August 30, 2016
Primary Completion Date
December 11, 2019
Study Completion Date
December 11, 2019
Secukinumab
Induction: Week 0,1,2,3 150 mg or 300 mg Secukinumab s.c. Maintenance: 150 mg or 300 mg Secukinumab s.c. every 4 weeks starting at Week 4
Secukinumab Placebo
Induction: Week 0,1,2,3 Secukinumab Placebo s.c. Maintenance: Secukinumab Placebo s.c. every 4 weeks starting at Week 4 until Week 24 followed by 150 or 300 mg Secukinumab s.c. every 4 weeks
Novartis Investigative Site, Sofia
Novartis Investigative Site, Sofia
Novartis Investigative Site, Plovdiv
Novartis Investigative Site, Stara Zagora
Novartis Investigative Site, Targovishte
Novartis Investigative Site, Torino
Novartis Investigative Site, Berlin
Novartis Investigative Site, Berlin
Novartis Investigative Site, Santiago de Compostela
Novartis Investigative Site, Milan
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Bergamo
Novartis Investigative Site, Madrid
Novartis Investigative Site, Madrid
Novartis Investigative Site, Madrid
Novartis Investigative Site, Málaga
Novartis Investigative Site, Hanover
Novartis Investigative Site, Cartagena
Novartis Investigative Site, Ourense
Novartis Investigative Site, Pontevedra
Novartis Investigative Site, Vigo
Novartis Investigative Site, Verona
Novartis Investigative Site, Magdeburg
Novartis Investigative Site, Magdeburg
Novartis Investigative Site, Torrelavega
Novartis Investigative Site, Bologna
Novartis Investigative Site, Seville
Novartis Investigative Site, Wuppertal
Novartis Investigative Site, Herne
Novartis Investigative Site, Barakaldo
Novartis Investigative Site, Cologne
Novartis Investigative Site, Thessaloniki
Novartis Investigative Site, Mainz
Novartis Investigative Site, Frankfurt am Main
Novartis Investigative Site, Brno
Novartis Investigative Site, Potenza
Novartis Investigative Site, Erlangen
Novartis Investigative Site, Piešťany
Novartis Investigative Site, Prague
Novartis Investigative Site, Prague
Novartis Investigative Site, Uherské Hradiště
Novartis Investigative Site, Cottbus
Novartis Investigative Site, Heraklion Crete
Novartis Investigative Site, Athens
Novartis Investigative Site, Athens
Novartis Investigative Site, Mérida
Novartis Investigative Site, Truro
Novartis Investigative Site, Leytonstone
Novartis Investigative Site, Stoke-on-Trent
Novartis Investigative Site, Barnsley
Novartis Investigative Site, Cheshire
Novartis Investigative Site, Hull
Novartis Investigative Site, London
Novartis Investigative Site, Tyne and Wear
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY